Dr Reddy's Laboratories

Dr Reddy's seeks emergency use authorisation for Russia's Sputnik V vaccine

23 Feb 2021

DRL gets DCGI nod for phase 2/3 human trials of Sputnik V Covid vaccine

19 Oct 2020

Dr Reddy’s to acquire select businesses of Wockhardt for Rs1.850 cr

13 Feb 2020

Wockhardt would transfer 62 of its brands in therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines as also its plant in Baddi, Himachal Pradesh along with all employees, including related sales and marketing teams to Dr Reddy’s on a slump sale basis

Dr Reddy's Q1 net profit rises 45% to Rs662.8cr on one-off gains

30 Jul 2019

Dr Reddy’s plummets on US lawsuit over ‘corporate quality’

28 Aug 2017

Mezzion Pharma sues Dr Reddy’s in US for ‘millions of dollars’

27 Jan 2017

Dr Reddy's, Sun Pharma under cartelisation probe in US

05 Nov 2016

Dr Reddy’s Lab gets USFDA approval to market `Sernivo’ spray for psoriasis

09 Feb 2016

Dr Reddy’s Q2 net flat at Rs580 cr; revenues up marginally at Rs3,970 cr

09 Feb 2016

FDA threatens Dr Reddy’s with US import ban

26 Nov 2015

FDA seeks third-party audit of all Dr Reddy’s plants

10 Nov 2015

Dr Reddy’s Laboratories signs commercialisation deal with Australia's Hatchtech

14 Sep 2015

Dr Reddy's Laboratories recalls Rivastigmine Tartrate capsules from US market

20 Aug 2015

Dr Reddy's Q1 net up 14% at Rs626 crore

30 Jul 2015

Dr Reddy's to buy some South Asian brands of Belgian drug company UCB for Rs800 crore

02 Apr 2015

Dr Reddy’s acquires quit-tobacco patch Habitrol from Novartis

19 Dec 2014

Dr Reddy's bulk drugs unit in Andhra gets US FDA fiat on procedural lapses

27 Nov 2014

Dr Reddy’s Lab recalls 13,560 bottles of heart drug in US

21 Jun 2014

Dr Reddy’s management rejig remains largely en famille

14 May 2014

Dr Reddy’s announces the Launch of Eszopiclone tablets C-IV

16 Apr 2014

TCS, Dr Reddy’s among 24 SEZ developers seeking more time, 3 others to surrender

17 Jan 2014

Dr Reddy’s, Fuji Corp terminate Japan partnership deal

03 Jun 2013

DRL founder-chairman Anji Reddy passes away

15 Mar 2013

Dr Anji Reddy made significant contribution to making Indian pharmaceutical products globally competitive and making medicines affordable to the common man

Dr Reddy's acquires 93 % shares of OctoPlus; extends offer till 26 February

12 Feb 2013

Dr Reddy’s Lab sued for patent infringement in US

27 Dec 2012